Hantech Bio-Technology Co., Ltd.

TPEX:1294 Stock Report

Market Cap: NT$2.0b

Hantech Bio-Technology Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure5.4yrs
Board average tenure5yrs

Recent management updates

Recent updates

CEO

Hantech Bio-Technology has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Xie Junyang
Chief Financial Officerno datano datano data
Geng Hao Liu
Accounting Supervisorno datano datano data
Laien Li
Deputy GM of General Administration Office3.7yrsno datano data
Yuxuan Li
Chief of Audit Section3.7yrsno datano data
Qihao Liu
Treasurer7.1yrsno datano data
Bizhen Yang
Deputy GM of Quality Assurance Department9.9yrsno datano data
5.4yrs
Average Tenure

Experienced Management: 1294's management team is seasoned and experienced (5.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Meijuan Yang
Director5yrsno datano data
Yulin Li
Chairman14.7yrsno datano data
Kin Wang Chan
Director7.2yrsno datano data
Zhenzhi Huang
Director9yrsno datano data
Shangwen Hong
Director10.1yrsno datano data
Qinglong Xie
Independent Director5yrsno datano data
Yuqi Wang
Independent Director5yrsno datano data
Chonggui Chen
Director5yrsno datano data
Jiancheng Zhu
Independent Director5yrsno datano data
5.0yrs
Average Tenure

Experienced Board: 1294's board of directors are considered experienced (5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/22 02:23
End of Day Share Price 2026/08/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hantech Bio-Technology Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hsiu Chi LinMasterlink Securities Investment Advisory
Kyeongkeun KangNH Investment & Securities Co., Ltd.